To date, ten studies have investigated the expression of B7-H4 in ovarian cancer tissues and/or the level of soluble B7-H4 in blood samples from the ovarian cancer patients [4, 9, 19, 23, 28–30, 35–38]. This evidence concerns the gene VTCN1 and ovarian carcinoma.